메뉴 건너뛰기




Volumn 39, Issue 12, 2009, Pages 847-849

Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: A placebo-controlled double-blind randomized phase II study (the GONE Study)

Author keywords

Colorectal cancer; Goshajinkigan; Japanese herbal medicine; Neurotoxicity; Oxaliplatin

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GOSHAJINKIGAN; HERBACEOUS AGENT; OXALIPLATIN; PLACEBO; UNCLASSIFIED DRUG;

EID: 70849136155     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp100     Document Type: Article
Times cited : (20)

References (8)
  • 1
    • 85026194034 scopus 로고    scopus 로고
    • NCCN Clinical Practice Guidelines in Oncology
    • Version 2
    • National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology. Colon Cancer - Version 2. 2009. http://www.nccn.org/ professionals/physician_gls/PDF/colon.pdf.
    • (2009) Colon Cancer
  • 2
    • 70849115279 scopus 로고    scopus 로고
    • NCCN Clinical Practice Guidelines in Oncology
    • Version 2
    • National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology. Rectal Cancer - Version 2. 2009. http://www.nccn.Org/ professionals/physician_gls/PDF/rectal.pdf.
    • (2009) Rectal Cancer
  • 3
    • 70849120140 scopus 로고    scopus 로고
    • Use of Goshajinkigan to reduce oxaliplatin-induced peripheral neurotoxicity in patients with metastatic colorectal cancer: Results of a retrospective study
    • abstract 326
    • Kono T, Mamiya N, Ebisawa Y, Yamamoto Y, Yamazaki H, Kasai S. Use of Goshajinkigan to reduce oxaliplatin-induced peripheral neurotoxicity in patients with metastatic colorectal cancer: Results of a retrospective study. Proc GI Cancer Symposium 2009;223 (abstract 326).
    • (2009) Proc GI Cancer Symposium , vol.223
    • Kono, T.1    Mamiya, N.2    Ebisawa, Y.3    Yamamoto, Y.4    Yamazaki, H.5    Kasai, S.6
  • 5
    • 34547924451 scopus 로고    scopus 로고
    • Phase II study of oxaliplatin in Japanese patients with metastatic colorectal cancer refractory to fluoropyrimidines
    • Boku N, Ohtsu A, Hyodo I, Shirao K, Miyata Y, Nakagawa K, et al. Phase II study of oxaliplatin in Japanese patients with metastatic colorectal cancer refractory to fluoropyrimidines. Jpn J Clin Cancer 2007;37:440-45.
    • (2007) Jpn J Clin Cancer , vol.37 , pp. 440-445
    • Boku, N.1    Ohtsu, A.2    Hyodo, I.3    Shirao, K.4    Miyata, Y.5    Nakagawa, K.6
  • 6
    • 33745714762 scopus 로고    scopus 로고
    • Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer
    • Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, et al. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer. Jpn J Clin Cancer 2006;36:218-23.
    • (2006) Jpn J Clin Cancer , vol.36 , pp. 218-223
    • Yamada, Y.1    Ohtsu, A.2    Boku, N.3    Miyata, Y.4    Shimada, Y.5    Doi, T.6
  • 7
    • 0033874892 scopus 로고    scopus 로고
    • Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
    • de Gramont A, Figer A, Seymour M, Homerin M, Hmirin A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938-47.
    • (2000) J Clin Oncol , vol.18 , pp. 2938-2947
    • de Gramont, A.1    Figer, A.2    Seymour, M.3    Homerin, M.4    Hmirin, A.5    Cassidy, J.6
  • 8
    • 1842569206 scopus 로고    scopus 로고
    • A randomized controlled trial of fluorouracil plus leucovorin, irinotecan and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
    • Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23-30.
    • (2004) J Clin Oncol , vol.22 , pp. 23-30
    • Goldberg, R.M.1    Sargent, D.J.2    Morton, R.F.3    Fuchs, C.S.4    Ramanathan, R.K.5    Williamson, S.K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.